Skip to content
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
About
Our Story
Global Network
Leadership
Financial Transparency
Our Work
What We Do
Where We Work
India
Pakistan
Bangladesh
Afghanistan
Sri Lanka
Get Involved
Events
Media Fellowship Program
GHHM
Donor’s Section
In Focus
Impact Stories
Reports
Issues We Focus On
Join MSF
Life at MSF
Explore Roles
Connect
Regional Offices
Media Contact
Donate
Donate
HR Login
MSF SA Login
›
topic: Tuberculosis
MSF responds to WHO’s annual global TB report: implores governments to use recent TB wins to beat back deadly infectious disease
Read More
MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction
Read More
Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need
Read More
MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics
Read More
TB medicine deal offers short-term solution, but J&J needs to do more for all affected countries
Read More
From Nhlangano to the Future, MSF’s legacy in Shiselweni region: 5 key facts about MSF in Eswatini
Read More
MSF demands J&J give up its patent monopoly on TB drug to put lives over profits
Read More
Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis
Read More
Between life and living: Patients with drug-resistant tuberculosis (DR-TB) share stories of strength, support and suffering
Read More
Emerging resistance to new anti-tuberculosis drug bedaquiline warrants urgent action: Médecins Sans Frontières (MSF) Policy Brief
Read More